Human Genome Sciences Stock Price, News & Analysis (NASDAQ:HGSI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Human Genome Sciences (NASDAQ:HGSI)

Human Genome Sciences logoHuman Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products include BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. HGS continues to deliver raxibacumab to the United States Strategic National Stockpile (SNS) for emergency use in treating inhalation anthrax. In addition to the Company's internal pipeline, it has financial rights to two drugs that GlaxoSmithKline (GSK) has advanced to late-stage development. These include darapladib and albiglutide. A randomized Phase 2 trial is evaluating mapatumumab in combination with Nexavar (sorafenib) for the treatment of advanced hepatocellular cancer. The Company manufactures multiple protein and antibody drugs for use in research, clinical and commercial activities. It produces and purifies these protein and antibody drugs in three process development and manufacturing facilities. In August 2012, GlaxoSmithKline plc acquired HGS.

Receive HGSI News and Ratings via Email

Sign-up to receive the latest news and ratings for HGSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Human Genome Sciences (NASDAQ:HGSI) Frequently Asked Questions

What is Human Genome Sciences' stock symbol?

Human Genome Sciences trades on the NASDAQ under the ticker symbol "HGSI."

Who are some of Human Genome Sciences' key competitors?

How do I buy Human Genome Sciences stock?

Shares of Human Genome Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Human Genome Sciences?

Human Genome Sciences' mailing address is 14200 Shady Grove Rd, ROCKVILLE, MD 20850-7464, United States. The biopharmaceutical company can be reached via phone at +1-301-3098504.

MarketBeat Community Rating for Human Genome Sciences (HGSI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about Human Genome Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Human Genome Sciences (NASDAQ:HGSI) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Human Genome Sciences (NASDAQ:HGSI) Earnings History and Estimates Chart

Earnings by Quarter for Human Genome Sciences (NASDAQ:HGSI)

Human Genome Sciences (NASDAQ HGSI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2012($0.37)($0.46)ViewN/AView Earnings Details
4/24/2012Q1 2012($0.40)($0.47)ViewN/AView Earnings Details
2/27/2012Q4 2011($0.42)($0.41)ViewN/AView Earnings Details
10/25/2011($0.38)($0.45)ViewN/AView Earnings Details
7/21/2011($0.41)($0.42)ViewN/AView Earnings Details
4/28/2011($0.48)($0.69)ViewN/AView Earnings Details
2/24/2011($0.38)($0.46)ViewN/AView Earnings Details
10/27/2010Q3 2010($0.36)($0.22)ViewN/AView Earnings Details
7/22/2010Q2 2010($0.26)($0.30)ViewN/AView Earnings Details
4/29/2010Q1 2010($0.20)($0.26)ViewN/AView Earnings Details
3/2/2010Q4 2009($0.09)($0.06)ViewN/AView Earnings Details
10/29/2009Q3 2009($0.28)($0.32)ViewN/AView Earnings Details
7/22/2009Q2 2009($0.35)($0.48)ViewN/AView Earnings Details
4/29/2009Q1 2009$0.49$0.56ViewN/AView Earnings Details
2/26/2009Q4 2008($0.48)($0.41)ViewN/AView Earnings Details
11/6/2008Q3 2008($0.50)($0.46)ViewN/AView Earnings Details
7/30/2008Q2 2008($0.55)($0.55)ViewN/AView Earnings Details
5/5/2008Q1 2008($0.25)($0.35)ViewN/AView Earnings Details
2/25/2008Q4 2007($0.49)($0.69)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Human Genome Sciences (NASDAQ:HGSI) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Human Genome Sciences (NASDAQ:HGSI)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Human Genome Sciences (NASDAQ HGSI)

No insider trades for this company have been tracked by


Human Genome Sciences (NASDAQ HGSI) News Headlines

No headlines for this company have been tracked by

SEC Filings

Human Genome Sciences (NASDAQ:HGSI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Human Genome Sciences (NASDAQ:HGSI) Income Statement, Balance Sheet and Cash Flow Statement


Human Genome Sciences (NASDAQ HGSI) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.